Medical Properties Trust, Inc. (MPT)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Medical Properties Trust, Inc..
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 2 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 4.60 $ — 30% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/04/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
Quality & Screener
AAQS
5/10The AAQS (AlleAktien Quality Score) checks 10 quality criteria on growth, profitability, and balance-sheet strength — per the methodology developed and published by AlleAktien, calculated by us from our own fundamental data. A stock counts as a quality stock from 9 out of 10 points. Where a company has a shorter listing history, we calculate over the fiscal years available (at least five).
- Sales growth 10Y > 5% 8.2%
- Exp. sales growth 3Y > 5% 5.5%
- EBIT growth 10Y > 5% 7.4%
- Exp. EBIT growth 3Y > 5% 5.5%
- Net debt < 4x EBIT 17.2x
- EBIT positive, 10Y straight –
- Max. EBIT decline < 50% –
- Return on equity > 15% -7.4%
- ROCE > 15% 3.9%
- Expected return > 10% 14.2%
View all AAQS quality stocks · Read the methodology at AlleAktien
Source: fundamental data
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Growth Score
6 of 10 Solid growthTen checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years -14.3% failed
- More than 10% revenue growth is expected for the coming year 5.6% failed
- Share count grows by less than 3% a year 0.1% passed
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") -1.5% failed
- Gross margin at 40% or higher and without meaningful erosion 96.3% passed
- Goodwill from acquisitions does not grow faster than revenue 0.0% passed
- Net debt below twice EBITDA 17.0 x EBITDA failed
- Operating cash flow covers the profits of the last three years 4,226 m passed
- Return on capital at 15% or higher, or up versus two years ago 3.9% passed
- Insiders hold at least 10% or are net buyers 17.6% passed
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Analysts & Price Target
The price target sits 24.1% above the current price.
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 0.11 | 0.11 – 0.11 | 1,035 | – | 1 |
| 12/31/2027 | 0.15 | 0.11 – 0.18 | 1,081 | 33.3% | 3 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Next Reporting Date
- Expected Earnings per Share
- 0.16 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | -0.69 | – | 235 | – | -175.50 | 77 | 77 |
| 2025: Q1 | -0.20 | – | 224 | -17.50 | -52.80 | 0 | 0 |
| 2025: Q2 | -0.16 | – | 240 | -9.80 | -40.90 | 52 | 52 |
| 2025: Q3 | -0.13 | – | 238 | 5.20 | -32.70 | 19 | 19 |
| 2025: Q4 | 0.03 | – | 270 | 14.90 | 6.40 | 160 | 160 |
| 2026: Q1 | 0.05 | – | 252 | 12.60 | 13.00 | -14 | -14 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2015 | 442 | 263 | 140 | 0.64 | 207 | 2,102 | 5,609 |
| 2016 | 541 | 342 | 225 | 0.86 | 265 | 3,248 | 6,419 |
| 2017 | 705 | 486 | 290 | 0.83 | 363 | 3,821 | 9,020 |
| 2019 | 870 | 750 | 375 | 0.87 | 494 | 7,028 | 14,467 |
| 2020 | 1,249 | – | 431 | 0.81 | 618 | 7,339 | 16,829 |
| 2021 | 1,545 | 1,039 | 656 | 1.11 | 812 | 8,440 | 20,520 |
| 2022 | 1,543 | 1,004 | 903 | 1.51 | 739 | 8,593 | 19,658 |
| 2023 | 872 | 81 | -556 | -0.93 | 506 | 7,632 | 18,305 |
| 2024 | 996 | 387 | -2,410 | -4.02 | 245 | 4,833 | 14,295 |
| 2025 | 972 | 540 | -277 | -0.46 | 231 | 4,608 | 15,002 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
Medical Properties Trust, Inc. ist ein selbstberatender Immobilien-Investmenttrust zum Erwerb und zur Entwicklung von net-leased Krankenhauseinrichtungen.
| Employees | 121 |
|---|---|
| Headquarters | Birmingham, AL |
| Address | 10500 Liberty Parkway, 35242 Birmingham, United States |
| Phone | 205 969 3755 |
| Website | medicalpropertiestrust.com |
| IPO Date | 8. Jul 2005 |
| ISIN | US58463J3041 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Edward K. Aldag Jr. | Founder, Chairman, President & CEO | 1964 |
| R. Steven Hamner CPA | Founder, Executive VP, CFO & Director | 1957 |
| James Kevin Hanna | Senior VP, Chief Accounting Officer, Controller & Assistant Treasurer | 1973 |
| Larry H. Portal | Senior VP & Senior Advisor to the CEO | 1970 |
| Charles R. Lambert | Senior VP of Finance & Treasurer | 1971 |
| Emmett E. McLean | Co-Founder | 1955 |
| Rosa H. Williams | Senior VP of Operations & Secretary | 1962 |
| R. Lucas Savage | VP & Head of Global Acquisitions | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 8. Jul 2026 | Lambert Charles R | SVP of Finance and Treasurer | Other | 2,347 | 4.61 | 10,820 |
| 8. Jul 2026 | Aldag Edward K JR | Chairman, President & CEO | Other | 109,433 | 4.61 | 504,486 |
| 8. Jul 2026 | Hanna James Kevin | Senior VP, Controller & CAO | Other | 3,295 | 4.61 | 15,190 |
| 8. Jul 2026 | Portal Larry H | SVP, Senior Advisor to the CEO | Other | 4,048 | 4.61 | 18,661 |
| 8. Jul 2026 | Hamner R Steven | Executive Vice President & CFO | Other | 48,548 | 4.61 | 223,806 |
| 8. Jul 2026 | Williams Rosa Handley | SVP of Operations | Other | 1,938 | 4.61 | 8,934 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Chart
Interactive price chart (TradingView).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.